4
Changes in Ownership
Relay Therapeutics, Inc. Filed Acc 0001209191-22-039654
President, R&D sold 8,999 shares at an average $20.03 ($180,290)
- President, R&D acquired 8,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bergstrom Donald A President, R&D | 2022-06-24 | Option exercise | +8,000 | $4.12 | $32,960 | 100,493 | D: show line 1 in the form |
| Bergstrom Donald A President, R&D | 2022-06-24 | Sale | −8,000 | $20.00 | $160,000 | 92,493 | D: show line 2 in the form |
| Bergstrom Donald A President, R&D | 2022-06-27 | Sale | −999 | $20.31 | $20,290 | 91,494 | D: show line 3 in the form |
| Open-market sales · 8,999 sh · avg $20.03 · $180,290 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bergstrom Donald A President, R&D | 2022-06-24 | Option exercise · Stock Option (Right to Buy) | −8,000 | 178,456 | D: show line 4 in the form |
Loading xslF345X03/doc4.xml…